Evotec
History
| Year | Detail |
|---|---|
| 1993 | Evotec was initially founded as Evotec BioSystems GmbH in Hamburg, Germany. |
| 1996 | Evotec collaborated with Novartis and SmithKlineBeecham to develop EVOscreen. |
| 1999 | The company established Evotec Neurosciences GmbH in Hamburg. |
| 2000 | Evotec merged with Oxford Asymmetry International plc and formed Evotec OAI AG. |
| 2006 | Evotec sold Evotec Technologies to PerkinElmer. |
| 2010 | Evotec collaborated with MedImmune in the diabetes therapeutic area. |
| 2012 | Evotec partnered its EVT100 series with Janssen Pharmaceuticals. |
| 2013 | Evotec acquired Cell Culture Service GmbH. |
| 2017 | Evotec acquired Aptuit. |
| 2019 | Evotec and Galapagos collaborated in the field of fibrosis. |
| 2020 | Evotec and Novo Nordisk partnered to develop novel therapies for kidney diseases. |
| 2021 | Evotec and Chinook Therapeutics collaborated to discover and develop novel precision medicines for chronic kidney diseases. |
| 2022 | Evotec and BMS extended and expanded their strategic partnership in protein degradation. |
| 2023 | Evotec and Bristol Myers Squibb extended a strategic neurodegeneration partnership. |
BCC Research Beacon 